Goldman Sachs’s Bioceres Crop Solutions BIOX Stock Holding History

Goldman Sachs’s Portfolio BIOX Stock Details BIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$45.3K	Buy	129,445 +12,570	+11%	+$5.91K	﹤0.01%	6423
2026 Q1	$52K	Buy	116,875 +9,234	+9%	+$7.01K	﹤0.01%	6294
2025 Q4	$141K	Buy	107,641 +81,924	+319%	+$131K	﹤0.01%	6128
2025 Q3	$36.3K	Buy	+25,717	New	+$78.4K	﹤0.01%	6203
2025 Q1	–	Sell	-12,012	Closed	-$73K	–	6069
2024 Q4	$73K	Sell	12,012 -5,860	-33%	-$40K	﹤0.01%	5812
2024 Q3	$141K	Buy	17,872 +4,211	+31%	+$42.5K	﹤0.01%	5530
2024 Q2	$153K	Sell	13,661 -7,749	-36%	-$90.6K	﹤0.01%	5328
2024 Q1	$271K	Buy	+21,410	New	+$282K	﹤0.01%	5015
2023 Q4	–	Sell	-15,532	Closed	-$175K	–	5628
2023 Q3	$175K	Buy	15,532 +2,388	+18%	+$28.6K	﹤0.01%	5071
2023 Q2	$176K	Buy	+13,144	New	+$154K	﹤0.01%	5225

Other funds holding BIOX

Solel Partners Boston, Massachusetts $588M AUM 14.47% 1-Year Est. Return

Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $83.9B AUM 60.43% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

PCM

Ping Capital Management New York $401M AUM 32.08% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs's BIOX Position: Q2 2026 in Review

Goldman Sachs increased its Bioceres Crop Solutions (BIOX) stake by 11% in Q2 2026, buying an estimated $5.91K and bringing the position to 129,445 shares worth $45.3K. The position accounts for ﹤0.01% of the portfolio, ranked #6423.

Goldman Sachs first reported a position in BIOX in Q2 2023 and has held it in 10 quarters since. The position peaked at $271K in Q1 2024. 28 funds tracked by Wall St. Rank hold BIOX as of Q2 2026.

Goldman Sachs held 129,445 shares of Bioceres Crop Solutions worth $45.3K as of Q2 2026.
Goldman Sachs bought 12,570 Bioceres Crop Solutions shares in Q2 2026, an estimated $5.91K.
Bioceres Crop Solutions made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #6423 holding.
Goldman Sachs first reported a position in Bioceres Crop Solutions in Q2 2023 and has held it in 10 quarters since.
Goldman Sachs's Bioceres Crop Solutions position peaked at $271K in Q1 2024.
28 funds tracked by Wall St. Rank held Bioceres Crop Solutions as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.